
NOCIL Q4 FY26 Earnings Call Analysis
Revenue, margin, capex, fundraise and order book outlook from management commentary.
Management growth scorecard
Revenue
Category 3
Margin
N/A
Fundraise
No
Order
N/A
Capex
Yes
1 of 3 growth signals are positive — mixed outlook.
Full analysisRevenue guidance
Category 3- →NOCIL targets double-digit volume growth for FY '27 and FY '28. (Page 18)
- →Volume growth momentum picked up in H2 FY '26, expected to continue into FY '27. (Page 6)
- →New plant expansions and customer approvals anticipated to drive volume increase, with material capacity utilization improvements expected 6-8 months post-sample submission. (Page 14)
- →New products are in a pickup phase in FY '27; meaningful volume contribution expected gradually toward year-end. (Page 14)
- →Export volumes, especially in the USA market, are recovering post-duty adjustments, supporting growth. (Page 14)
- →Domestic market demand growth expected to be around 7%, supported by tyre industry growth, with cautious supply chain management. (Page 16)
- →Growth expected to be supported by product mix improvements, cost efficiencies, and geographical expansion. (Pages 16 & 17)
Margin guidance
- →NOCIL targets double-digit volume growth for FY '27 and FY '28. (Page 18)
- →The company aims to improve EBITDA margins by approximately 150 basis points from FY '26 levels through operational efficiencies and cost measures. (Page 14)
- →New product volumes are expected to pick up progressively in FY '27, with a more significant impact towards year-end, aiding volume growth though the exact contribution is uncertain. (Page 14)
- →Expansion projects including a Rs.130 crore capex and Rs.250 crore Dahej plant expansion are expected to increase merchant sales volumes and improve operating leverage. (Pages 13 & 7)
- →The operating leverage from volume growth and new capacities should positively impact profits and margins. (Page 14 & 12)
- →No expected reduction in tax rates for FY '27; normal tax rates anticipated. (Page 18)
- →Margin improvement expected even if antidumping duty protection is not materialized, via mix, efficiency, specialty growth, and geographic expansion. (Page 14 & 18)
3 more insights locked — sign up free to unlock
Fundraise plans
No- →As of FY '26, NOCIL Limited has not borrowed any debt, although it has secured bank lines above Rs.100 crores available for utilization when needed.
- →The cost of debt, if utilized, will be linked to repo rates.
- →The company currently has Rs.220 crores of Capital Work In Progress (CWIP), but no project debt has been drawn yet.
- →Regarding future capex, including the announced Rs.130 crores brownfield expansion, and Rs.250 crores Dahej expansion, financing largely comes from internal working capital efficiencies rather than external debt.
- →There was no mention of any plans for equity fundraising or additional debt in the near term during this period.
- →The company remains focused on managing operations and capex through internal cash flows and working capital optimization.
Order book
Capex plans
Yes- →Rs.130 crores capex focused largely on specialty segment, expected to be commissioned by FY '28, aiming to increase specialty product mix from ~15% to 20%. (Page 17)
- →Rs.250 crores capex at Dahej for incremental capacity expansion, increasing capacity by roughly 20%, targeting merchant sales. (Page 8 & 17)
- →The Rs.130 crores capex includes some intermediates and is largely for captive consumption, with part allocated to finished goods. (Page 8)
- →Capex largely internally funded through working capital efficiency without current debt borrowing, with bank lines available if needed at repo-linked rates. (Page 18)
- →New facility in specialty chemicals at Dahej expected to be ready by H1 FY '28, part of integrated expansion strategy. (Page 4)
- →Focus on brownfield expansion with new capacities, not just debottlenecking. (Page 8)
How does NOCIL rank vs peers in Chemicals & Petrochemicals?
Pro featureSee full Chemicals & Petrochemicals sector rankings
How does NOCIL rank in Chemicals & Petrochemicals?
Compare NOCIL against every Chemicals & Petrochemicals company (Q4 FY26) on revenue, margins and earnings-call signals.